Overview of Transaction

• On March 13, 2017, Eliza announced its strategic sale to HMS in one of the largest Healthcare Technology and Services deals of the year
• HMS will acquire Eliza for a cash purchase price of $170 million
• Headquartered in Danvers, MA and majority owned by Parthenon Capital Partners, Eliza is a leading engagement and population analytics platform integrating proprietary data assets, a deep understanding of the healthcare consumer, and omni-channel outreach technology to deliver mission-critical results for key constituents in the healthcare market
• Since its founding in 2000, Eliza has consistently been a market leader and innovator, as evidenced by more than 50 domestic and international patents and patent applications, which HMS will acquire
• HMS operates in the healthcare insurance benefit cost containment market, using innovative technology and powerful data services and analytics to cover the entire payment continuum including eligibility verification, payment accuracy, fraud prevention, cost savings, performance improvement and provider education

Significance of Transaction

• The acquisition further expands HMS’ member health and care management analytics footprint
• Eliza’s engagement platform is complementary to HMS’ cost containment solutions and together create a more sophisticated and integrated platform

FT Partners' Role

• FT Partners leveraged its deep domain expertise and transactional experience in the Healthcare and Insurance Services market to generate a highly successful outcome for Eliza and its shareholders
• This transaction demonstrates FT Partners’ continued leadership position as the “advisor of choice” to the highest quality FinTech companies